| SLDB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SLDB shares outstanding history going back to 1/26/2018:
Also see: SLDB Market Cap History SLDB YTD Return |
SLDB Shares Outstanding History — Solid Biosciences Share Count Over Time
As of 5/8/2026 Solid Biosciences has 98.45 million SLDB shares outstanding. Investors often track the SLDB shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SLDB share count trends over time, with 36 historical shares outstanding datapoints presented, dating back to 1/26/2018.
| SLDB Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SLDB Historical Shares Outstanding: +58.69% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SLDB Stock Price Chart |
| About Solid Biosciences Inc |
| Solid Biosciences Inc. is a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases. Co. is focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy, and additional assets for the treatment of fatal cardiac diseases. Co. also has two cardiac pipeline gene transfer programs, SGT-601 for TNNT2 DCM and SGT-701 for RBM20 DCM, that are both in early preclinical development. We show 36 historical shares outstanding datapoints in our coverage of SLDB's shares outstanding history. Understanding the changing numbers of SLDB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SLDB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SLDB by allowing them to research SLDB shares outstanding history as well as any other stock in our coverage universe. |
| SLDB Current Stock Quote |
Quotes delayed 20 minutes  Free SLDB Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SLDB Share Performance |
| Shares Outstanding Peers |
| Solid Biosciences (SLDB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SLNO Shares Outstanding History SLRN Shares Outstanding History SLRX Shares Outstanding History SLS Shares Outstanding History SMLR Shares Outstanding History SMMT Shares Outstanding History SMTI Shares Outstanding History SNBP Shares Outstanding History SNCA Shares Outstanding History SNDA Shares Outstanding History More Healthcare companies » |
SLDB Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
